LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 1797

Search options

  1. Article ; Online: PLATELET FUNCTION IN TRAUMA: IS CURRENT TECHNOLOGY IN FUNCTION TESTING MISSING THE MARK IN INJURED PATIENTS?

    Schriner, Jacob B / George, Mitchell J / Cardenas, Jessica C / Olson, Scott D / Mankiewicz, Kimberly A / Cox, Charles S / Gill, Brijesh S / Wade, Charles E

    Shock (Augusta, Ga.)

    2022  Volume 58, Issue 1, Page(s) 1–13

    Abstract: Abstract: Platelets are subcellular anucleate components of blood primarily responsible for initiating and maintaining hemostasis. After injury to a blood vessel, platelets can be activated via several pathways, resulting in changed shape, adherence to ... ...

    Abstract Abstract: Platelets are subcellular anucleate components of blood primarily responsible for initiating and maintaining hemostasis. After injury to a blood vessel, platelets can be activated via several pathways, resulting in changed shape, adherence to the injury site, aggregation to form a plug, degranulation to initiate activation in other nearby platelets, and acceleration of thrombin formation to convert fibrinogen to fibrin before contracting to strengthen the clot. Platelet function assays use agonists to induce and measure one or more of these processes to identify alterations in platelet function that increase the likelihood of bleeding or thrombotic events. In severe trauma, these assays have revealed that platelet dysfunction is strongly associated with poor clinical outcomes. However, to date, the mechanism(s) causing clinically significant platelet dysfunction remain poorly understood. We review the pros, cons, and evidence for use of many of the popular assays in trauma, discuss limitations of their use in this patient population, and present approaches that can be taken to develop improved functional assays capable of elucidating mechanisms of trauma-induced platelet dysfunction. Platelet dysfunction in trauma has been associated with need for transfusions and mortality; however, most of the current platelet function assays were not designed for evaluating trauma patients, and there are limited data regarding their use in this population. New or improved functional assays will help define the mechanisms by which platelet dysfunction occurs, as well as help optimize future treatment.
    MeSH term(s) Blood Platelets/metabolism ; Fibrin/metabolism ; Hemostasis/physiology ; Humans ; Platelet Aggregation ; Platelet Function Tests/methods ; Thrombosis ; Wounds and Injuries/metabolism
    Chemical Substances Fibrin (9001-31-4)
    Language English
    Publishing date 2022-07-19
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1185432-7
    ISSN 1540-0514 ; 1073-2322
    ISSN (online) 1540-0514
    ISSN 1073-2322
    DOI 10.1097/SHK.0000000000001948
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Mark Blaug on the normativity of welfare economics

    Hands, D. Wade / Blaug, Mark

    Erasmus journal for philosophy and economics : EJPE Vol. 6, No. 3 , p. 1-25

    2013  Volume 6, Issue 3, Page(s) 1–25

    Author's details D. Wade Hands
    Keywords positive and normative economics ; Pareto optimality ; welfare economics ; ethical and methodological norms ; Blaug-Hennipman debate
    Language English
    Size Online-Ressource
    Publisher Erasmus Univ
    Publishing place Rotterdam
    Document type Article ; Online
    ZDB-ID 2474551-0
    ISSN 1876-9098
    Database ECONomics Information System

    More links

    Kategorien

  3. Article: The MBD protein family-reading an epigenetic mark?

    Dhasarathy, Archana / Wade, Paul A

    Mutation research

    2008  Volume 647, Issue 1-2, Page(s) 39–43

    Abstract: A family of proteins conserved throughout the eukaryotic lineage is characterized by the presence of a common sequence motif-the methyl-CpG-binding domain, or MBD. This sequence motif corresponds to a structural domain which, in some but not all cases, ... ...

    Abstract A family of proteins conserved throughout the eukaryotic lineage is characterized by the presence of a common sequence motif-the methyl-CpG-binding domain, or MBD. This sequence motif corresponds to a structural domain which, in some but not all cases, confers the ability to bind methylated cytosine residues in the context of the dinucleotide 5' CG 3'. Mammals have five well-characterized members of this family, each with unique biological characteristics. Recently, much progress has been made in defining the biochemical properties of one member of this family, MeCP2. This protein has a very high affinity for chromatin and considerable insight has been gained into its interactions with naked DNA and with chromatin fibers. Previous models have proposed that several members of the MBD family contribute to establishment and/or maintenance of transcriptional repression by recruiting enzymes that locally modify histones. Surprisingly, recent data indicate that MeCP2 is likely to contribute to chromatin properties through an architectural role, participating in higher order chromatin structures that facilitate both gene repression as well as gene activation. These observations suggest that existing models probably do not explain the entire gamut of biological functions performed by this very interesting protein family.
    MeSH term(s) Amino Acid Sequence ; Animals ; DNA Methylation ; DNA-Binding Proteins/genetics ; Epigenesis, Genetic ; Humans ; Molecular Sequence Data ; Protein Structure, Tertiary
    Chemical Substances DNA-Binding Proteins ; MBD2 protein, human
    Language English
    Publishing date 2008-07-22
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, N.I.H., Intramural ; Review
    ZDB-ID 206607-5
    ISSN 1873-135X ; 0027-5107 ; 1383-5718 ; 0165-1110 ; 0165-1161 ; 0165-7992 ; 0921-8777 ; 0165-1218 ; 1383-5726 ; 0167-8817 ; 0921-8734 ; 1383-5742
    ISSN (online) 1873-135X
    ISSN 0027-5107 ; 1383-5718 ; 0165-1110 ; 0165-1161 ; 0165-7992 ; 0921-8777 ; 0165-1218 ; 1383-5726 ; 0167-8817 ; 0921-8734 ; 1383-5742
    DOI 10.1016/j.mrfmmm.2008.07.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Design of the POSSIBLE UStrade mark Study: postmenopausal women's compliance and persistence with osteoporosis medications.

    Barrett-Connor, E / Ensrud, K / Tosteson, A N A / Varon, S F / Anthony, M / Daizadeh, N / Wade, S

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

    2008  Volume 20, Issue 3, Page(s) 463–472

    Abstract: Unlabelled: Failure to take prescribed medication is common. The POSSIBLE US study is evaluating the impact of physician and patient characteristics on patient-reported compliance and persistence with osteoporosis medications. We report our study design ...

    Abstract Unlabelled: Failure to take prescribed medication is common. The POSSIBLE US study is evaluating the impact of physician and patient characteristics on patient-reported compliance and persistence with osteoporosis medications. We report our study design and the baseline characteristics of 4,994 postmenopausal women recruited from primary care physician offices in 33 states.
    Introduction: The Prospective Observational Scientific Study Investigating Bone Loss Experience (POSSIBLE US) is a longitudinal cohort study of osteoporosis therapy in primary care.
    Methods: Between 2004 and 2007, 134 physicians (in 33 states) enrolled postmenopausal women initiating, changing, or continuing osteoporosis medications. After completing a baseline questionnaire, participants will provide data semi-annually for up to 3 years through 2008. Physicians provide patient data at baseline and routine follow-up visits. Participants from 23 sites also signed a release regarding administrative claims data for economic analyses and validation of self-reported data.
    Baseline results: Four thousand nine hundred and ninety-four evaluable women were recruited from internal medicine (n = 1,784), family practice (n = 1,556), obstetrics/gynecology (n = 1,556), and from one rheumatology practice (n = 98). Mean participant age was 64.3 years (SD = 9.97); 89% were Caucasian; 59% had some college education. Sixty-three percent used a single osteoporosis agent, usually a bisphosphonate. For monotherapy patients, concordance between clinic- and patient-reported medication use was lowest for patients prescribed estrogen therapy (70%) or calcium/vitamin D (72%). Obstetrician/gynecologists enrolled younger women, who were more likely to use estrogen therapy than patients enrolled by other physicians. The 934 women (19%) prescribed only calcium/vitamin D were younger than women prescribed pharmacologic therapy.
    Conclusions: POSSIBLE US provides a unique foundation for evaluating longitudinal use of osteoporosis medications and related outcomes.
    MeSH term(s) Aged ; Bone Density Conservation Agents/therapeutic use ; Calcium, Dietary/therapeutic use ; Estrogen Replacement Therapy/statistics & numerical data ; Female ; Humans ; Medication Adherence ; Middle Aged ; Osteoporosis, Postmenopausal/drug therapy ; Physician-Patient Relations ; Primary Health Care ; Prospective Studies ; Research Design ; Self Administration ; United States ; Vitamin D/therapeutic use
    Chemical Substances Bone Density Conservation Agents ; Calcium, Dietary ; Vitamin D (1406-16-2)
    Language English
    Publishing date 2008-07-08
    Publishing country England
    Document type Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 1064892-6
    ISSN 1433-2965 ; 0937-941X
    ISSN (online) 1433-2965
    ISSN 0937-941X
    DOI 10.1007/s00198-008-0674-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Photographic mark-recapture analysis of clustered mammal-eating killer whales around the Aleutian Islands and Gulf of Alaska

    Durban, J / Ellifrit, D / Dahlheim, M / Waite, J / Matkin, C / Barrett-Lennard, L / Ellis, G / Pitman, R / LeDuc, R / Wade, P

    Marine biology. 2010 July, v. 157, no. 7

    2010  

    Abstract: We used photographic mark-recapture methods to estimate the number of mammal-eating “transient ...

    Abstract We used photographic mark-recapture methods to estimate the number of mammal-eating “transient” killer whales using the coastal waters from the central Gulf of Alaska to the central Aleutian Islands, around breeding rookeries of endangered Steller sea lions. We identified 154 individual killer whales from 6,489 photographs collected between July 2001 and August 2003. A Bayesian mixture model estimated seven distinct clusters (95% probability interval = 7-10) of individuals that were differentially covered by 14 boat-based surveys exhibiting varying degrees of association in space and time. Markov Chain Monte Carlo methods were used to sample identification probabilities across the distribution of clusters to estimate a total of 345 identified and undetected whales (95% probability interval = 255-487). Estimates of covariance between surveys, in terms of their coverage of these clusters, indicated spatial population structure and seasonal movements from these near-shore waters, suggesting spatial and temporal variation in the predation pressure on coastal marine mammals.
    Keywords Monte Carlo method ; Otariidae ; coastal water ; covariance ; photographs ; population structure ; predation ; probability ; probability distribution ; seasonal migration ; surveys ; temporal variation ; whales ; Aleutian Islands ; Gulf of Alaska
    Language English
    Dates of publication 2010-07
    Size p. 1591-1604.
    Publisher Springer-Verlag
    Publishing place Berlin/Heidelberg
    Document type Article
    ZDB-ID 1117-4
    ISSN 1432-1793 ; 0025-3162
    ISSN (online) 1432-1793
    ISSN 0025-3162
    DOI 10.1007/s00227-010-1432-6
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article: Design of the POSSIBLE US[trade mark sign] Study: postmenopausal women's compliance and persistence with osteoporosis medications

    Barrett-Connor, E / Ensrud, K / Tosteson, A. N. A / Varon, S. F / Anthony, M / Daizadeh, N / Wade, S

    Osteoporosis international a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2009 Mar., v. 20, no. 3

    2009  

    Abstract: Summary Failure to take prescribed medication is common. The POSSIBLE US[trade mark sign] study is ... Observational Scientific Study Investigating Bone Loss Experience (POSSIBLE US[trade mark sign]) is ... prescribed pharmacologic therapy. Conclusions POSSIBLE US[trade mark sign] provides a unique foundation ...

    Abstract Summary Failure to take prescribed medication is common. The POSSIBLE US[trade mark sign] study is evaluating the impact of physician and patient characteristics on patient-reported compliance and persistence with osteoporosis medications. We report our study design and the baseline characteristics of 4,994 postmenopausal women recruited from primary care physician offices in 33 states. Introduction The Prospective Observational Scientific Study Investigating Bone Loss Experience (POSSIBLE US[trade mark sign]) is a longitudinal cohort study of osteoporosis therapy in primary care. Methods Between 2004 and 2007, 134 physicians (in 33 states) enrolled postmenopausal women initiating, changing, or continuing osteoporosis medications. After completing a baseline questionnaire, participants will provide data semi-annually for up to 3 years through 2008. Physicians provide patient data at baseline and routine follow-up visits. Participants from 23 sites also signed a release regarding administrative claims data for economic analyses and validation of self-reported data. Baseline results Four thousand nine hundred and ninety-four evaluable women were recruited from internal medicine (n = 1,784), family practice (n = 1,556), obstetrics/gynecology (n = 1,556), and from one rheumatology practice (n = 98). Mean participant age was 64.3 years (SD = 9.97); 89% were Caucasian; 59% had some college education. Sixty-three percent used a single osteoporosis agent, usually a bisphosphonate. For monotherapy patients, concordance between clinic- and patient-reported medication use was lowest for patients prescribed estrogen therapy (70%) or calcium/vitamin D (72%). Obstetrician/gynecologists enrolled younger women, who were more likely to use estrogen therapy than patients enrolled by other physicians. The 934 women (19%) prescribed only calcium/vitamin D were younger than women prescribed pharmacologic therapy. Conclusions POSSIBLE US[trade mark sign] provides a unique foundation for evaluating longitudinal use of osteoporosis medications and related outcomes.
    Keywords cohort studies ; compliance ; osteoporosis ; prospective studies
    Language English
    Dates of publication 2009-03
    Size p. 463-472.
    Publisher Springer-Verlag
    Publishing place London
    Document type Article
    ZDB-ID 1064892-6
    ISSN 1433-2965 ; 0937-941X
    ISSN (online) 1433-2965
    ISSN 0937-941X
    DOI 10.1007/s00198-008-0674-3
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  7. Article ; Online: Omitted Acknowledgment of Local Contributors to Study.

    Wade, Mark

    JAMA psychiatry

    2019  Volume 76, Issue 4, Page(s) 447

    Language English
    Publishing date 2019-02-26
    Publishing country United States
    Document type Journal Article ; Published Erratum
    ZDB-ID 2701203-7
    ISSN 2168-6238 ; 2168-622X
    ISSN (online) 2168-6238
    ISSN 2168-622X
    DOI 10.1001/jamapsychiatry.2018.4596
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Embedding the A-EQUIP model of restorative supervision in a critical care unit by professional nurse advocates.

    Wade, Rachel

    British journal of nursing (Mark Allen Publishing)

    2023  Volume 32, Issue 15, Page(s) 744–747

    Abstract: The professional nurse advocate (PNA) programme was launched in March 2021, which was towards the end of the third wave of COVID-19 and the start of a critical point of recovery. COVID-19 placed exceptional challenges and pressure on healthcare staff, ... ...

    Abstract The professional nurse advocate (PNA) programme was launched in March 2021, which was towards the end of the third wave of COVID-19 and the start of a critical point of recovery. COVID-19 placed exceptional challenges and pressure on healthcare staff, with many experiencing feelings of stress and burnout. The role of the PNA emerged as a response to the impact this had upon the nursing workforce. PNAs are trained to facilitate restorative clinical supervision and to advocate education for quality improvement, resulting in improvements to patient care and staff wellbeing. The programme started with 400 critical care nurses; since then it has been rolled out to all specialties, with the aim to have 5000 PNAs integrated into the national workforce by April 2022. Criteria for the level 7 PNA training programme requires a registered nurse to be working in a patient-facing role, at band 5 or above, hold a level 6 qualification and have approval from their line manager. The training programme is typically 10 to 12 days in length over a 12-week period. This article explores the implementation of the PNA role in a critical care unit.
    MeSH term(s) Humans ; Peptide Nucleic Acids ; COVID-19 ; Intensive Care Units ; Critical Care ; Workforce
    Chemical Substances Peptide Nucleic Acids
    Language English
    Publishing date 2023-07-06
    Publishing country England
    Document type Journal Article
    ZDB-ID 1119191-0
    ISSN 0966-0461
    ISSN 0966-0461
    DOI 10.12968/bjon.2023.32.15.744
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Polymicrobial Purulent Pericarditis From a Pancreatico-Pericardial Fistula.

    Richardson, Christopher / Cromer, Mark / Tatem, Luis / Wade, Raymond / Russell, Derek

    JACC. Case reports

    2024  Volume 29, Issue 7, Page(s) 102288

    Abstract: A 54-year-old male with chronic pancreatitis presented with dyspnea. Computed tomography scans demonstrated a subdiaphragmatic fluid collection with pericardial fistulization. Pericardial fluid cultures were polymicrobial in nature. Purulent pericarditis ...

    Abstract A 54-year-old male with chronic pancreatitis presented with dyspnea. Computed tomography scans demonstrated a subdiaphragmatic fluid collection with pericardial fistulization. Pericardial fluid cultures were polymicrobial in nature. Purulent pericarditis is rare but carries a high mortality rate. We present the first documented case of pancreatico-pericardial fistulization causing purulent pericarditis.
    Language English
    Publishing date 2024-03-05
    Publishing country Netherlands
    Document type Journal Article
    ISSN 2666-0849
    ISSN (online) 2666-0849
    DOI 10.1016/j.jaccas.2024.102288
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Why we still need longitudinal mental health research with children and youth during (and after) the COVID-19 pandemic.

    Wade, Mark / Prime, Heather / Browne, Dillon T

    Psychiatry research

    2023  Volume 323, Page(s) 115126

    MeSH term(s) Adolescent ; Child ; Humans ; COVID-19 ; Mental Health ; Pandemics
    Language English
    Publishing date 2023-02-22
    Publishing country Ireland
    Document type Letter
    ZDB-ID 445361-x
    ISSN 1872-7123 ; 1872-7506 ; 0925-4927 ; 0165-1781
    ISSN (online) 1872-7123 ; 1872-7506
    ISSN 0925-4927 ; 0165-1781
    DOI 10.1016/j.psychres.2023.115126
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top